Reporting of SM and other mast cell disorders is rising, study finds
The use of diagnostic codes for mast cell disorders, such as systemic mastocytosis (SM), appears to be on the rise.
The use of diagnostic codes for mast cell disorders, such as systemic mastocytosis (SM), appears to be on the rise.
Patients with indolent SM experience significant limitations in their daily lives that directly correlate with symptom burden.
Learn about the current challenges and emergent therapies for bone health in patients with indolent SM.
A recent case study highlights how anemia and low platelet counts can be the initial presentation of systemic mastocytosis (SM).
A recently published case report highlighted systemic mastocytosis (SM) as a possible cause of chronic diarrhea.
Different KIT mutations in patients with systemic mastocytosis (SM) appear to correlate with certain findings under the microscope.
The clinical manifestations of SM vary greatly from patient to patient, with some presenting back pain as an isolated symptom.
A rare case of systemic mastocytosis (SM) manifesting as generalized seizures was recently described in a case report.
Non-white patients with systemic mastocytosis appear to have a longer diagnostic journey and a greater disease burden than white patients.
Though patients with ISM have a normal life expectancy, they need more health care visits and medications than the general population.